Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli

Journal of Infectious Diseases

Volumn 177, Issue 3, 1998, Pages 662-667

  Freedman, Daniel J ^b   Tacket, Carol O ^b   Delehanty, Ann ^b   Maneval, David R ^b   Nataro, James ^b   Crabb, Joseph H ^a  

^a ImmuCell Corporation   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; ESCHERICHIA ENTEROTOXIN; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN G; LACTOSE; PLACEBO; VIRULENCE FACTOR;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; ESCHERICHIA COLI; HUMAN; MILK; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

EID: 0031886783     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514227     Document Type: Article

References (27)

1. Black RE. Epidemiology of travelers' diarrhea. Rev Infect Dis 1990;12: S73-7.
2. Farthing M, Keusch G. Enteric infections. New York: Raven Press, 1989.
3. Gorbach S, Edelman R. Travelers' diarrhea: National Institutes of Health Consensus Development Converence. Rev Infect Dis 1986;8(suppl 2):S227-33.
4. Cravioto A, Reyes R, Ortega R, Fernandez G, Hernandez R, Lopez D. Prospective pathogens during the first two years of life. Epidemiol Infect 1988;101:123-34.
5. Ericsson C, DuPont H. Travelers' diarrhea: approaches to prevention and treatment. Clin Infect Dis 1993;15:616-26.
6. Hyams KC, Bourgeois A, Merrell B, et al. Diarrheal disease during Desert Shield. N Engl J Med 1991;325:1423-8.
7. Ungar B, Ward D, Payer R, Quin C. Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology 1990;98:486-9.
8. Tzipori S, Roberton D, Cooper D, White L. Chronic cryptosporidial diarrhea and hyperimmune cow colostrum. Lancet 1987;2:344-5.
9. Ebina T, Sato A, Umezu K, et al. Prevention of rotavirus infection by oral administration of cow colostrum containing anti-human rotavirus antibody. Med Microbiol Immunol 1985;174:177-85.
10. Hilpert H, Burssow H, Mietens C, Siditi J, Lerner L, Wechau W. Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis 1987;156:156-66.
11. Tacket CO, Binion S, Bostwick E, Losonsky E, Roy M, Edelman R. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am J Trop Med Hyg 1992;47:276-83.
12. Lyerly D, Bostwick E, Binion S, Wilkins T. Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun 1991;59:2215-8.
13. Tjellstrom B, Stenhammar L, Eriksson S, Magnuson K. Oral immunoglobulin A supplement in treatment of Clostridium difficile enteritis. Lancet 1993;341:701-4.
14. McClead R, Butler T, Rabbani G. Orally administered bovine colostral anti-cholera toxin antibodies: results of two clinical trials. Am J Med 1988;85:811-6.
15. Tacket CO, Losonsky G, Link G, et al. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med 1988;318:1240-3.
16. Laemmli U. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
17. Binsztein N, Jouve M, Viboud G, et al. Colonization factors of enterotoxigenic Escherichia coli Isolated from children with diarrhea in argentina. J Clin Microbiol 1991;29:1893-8.
18. Gothefors L, Ahren C, Stoll B, et al. Presence of colonization factor antigens on fresh isolates of fecal Escherichia coli: a prospective study. J Infect Dis 1985;152:1128-33.
19. Wolf M, Taylor D, Boedeker E, et al. Characterization of enterotoxigenic Escherichia coli isolated from troops deployed to the Middle East. J Clin Microbiol 1993;31:851-6.
20. Evans DG, Evans DJ, Tjoa W, DuPont H. Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun 1978;19:727-36.
21. McConnell M, Hibberd M, Penny M, Scotland S, Cheasty T, Rowe B. Surveys of human enterotoxigenic Escherichia coli from three different geographical areas for possible colonization factors. Epidemiol Infect 1991;106:477-84.
22. Levine M, Ferreccio C, Prado V, et al. Epidemiologic studies of Escherichia coli diarrheal infections in a low socioeconomic level peri-urban community in Santiago, Chile. Am J Epidemiol 1993;138:849-69.
23. DuPont H, Ericsson C, DuPont M. Emporiatric enteritis: lessons learned from U.S. students in Mexico. Trans Am Clin Climatol Assoc 1985;97:32-42.
24. Levine MM. Changes in human ecology and behavior in relation to the emergence of diarrheal diseases, including cholera. Proc Natl Acad Sci USA 1994;91:2390-4.
25. Bourgeous A, Gardiner C, Thornton S, et al. Etiology of acute diarrhea among United States personnel deployed to South America and West Africa. Am J Trop Med Hyg 1993;48:243-8.
26. Haberberger R, Scott D. Diarrheal disease aboard a U.S. Navy ship after a brief port visit to a high risk area. Mil Med 1994;159:445-8.
27. Sharp T, Thornton S, Wallace M, et al. Diarrheal disease among military personnel during operation Restore Hope, Somalia, 1992-1993. Am J Trop Med Hyg 1995;52:188-93.